Intercept Pharma (ICPT) Tops Q1 EPS by 9c

Intercept Pharma (NASDAQ: ICPT) reported Q1 EPS of ($2.86), $0.09 better than the analyst estimate of ($2.95). Revenue for the quarter came in at $72.7 million versus the consensus estimate of $69.66 million.

For earnings history and earnings-related data on Intercept Pharma (ICPT) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• SVB & T Corporation (SVBT) Tops Q2 EPS by 275c
• Tvardi Therapeutics (TVRD) Tops Q2 EPS by 1c